Physician profile
Jacob Januszewski
NPI 1053610808
$5,244.87
in general payments reported to CMS, 2019-2025
12 companies · $74.25 in 2025
The $74.25 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $907 · 2020: $213 · 2021: $2,874 · 2022: $1,066 · 2024: $111 · 2025: $74.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $184.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $4,137.05 | 2019-2025 | Other - Miscellaneous |
| Abbott Laboratories | $265.01 | 2020-2021 | |
| Aesculap Implant Systems, LLC | $229.67 | 2022 | |
| Medtronic USA, INC. | $168.85 | 2019 | |
| Stryker Corporation | $133.64 | 2021 | |
| Highridge Medical LLC | $110.70 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Amgen INC. | $47.76 | 2020 | |
| Novocure INC. | $44.64 | 2019 | |
| Aesculap, INC. | $33.40 | 2019 | |
| Portola Pharmaceuticals, LLC | $29.77 | 2019 | |
| Zimmer Biomet Holdings, INC. | $25.14 | 2019 | |
| Si-Bone, INC. | $19.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Januszewski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.